InfoStrength, a developer of enterprise and IT solutions, will introduce two new products this week at the Drug Information Association meeting in Washington, DC.

Both are based on Microsoft applications.

“InfoStrength’s leading technology applications offer life science organizations innovative tools to address the regulatory challenges faced by the industry and to realize efficiencies throughout the drug life cycle,” said Steve Chin, Global Life Sciences Industry Manager at Microsoft, in a statement. “Based on Microsoft’s proven technology, these solutions enable customers to achieve increased productivity and improved quality across the enterprise at a lower total cost of ownership.”

An InfoStrength client will launch a validated clinical trial system as well as the “Smart Enterprise Suite” of applications for managing regulatory compliance.

“Our client is launching a validated system that creates a web-enabled clinical trial collaborative environment built on Microsoft .NET Framework,” said Rita Geiger, president and CEO of InfoStrength. “The product offers improved drug-tracking capabilities, data collection, and clinical trial management that reduces data duplication and provides real time tracking of a trial’s progress to meet the unique needs of small clinical trials.”